Qatar's largest IVF Institution Places MENA Orders for Felix
Filed with ASX · · 4 pages · English
Memphasys Limited (ASX: MEM) (“Memphasys” or “the Company”) is pleased to confirm that Hamad Medical Corporation (HMC), one of Qatar’s largest and most prominent fertility providers, has committed to commencing commercial in-clinic use of the Felix™ system, including ongoing orders of Felix™ cartridges given that CE-Mark approval allows for the immediate use of Felix in the country. This represent
Earlier from Memphasys
- Memphasys Extends Convertible Note Repayment Terms
- Placement of Shortfall Securities from the Entitlement Offer
- Memphasys Secures CE Mark Approval for Felix System
- Memphasys Secures Long-Term European Supply Agreement
- Key MENA Partner Secures Early Felix Cartridge Order
Later from Memphasys
- Regulatory Submissions Lodged for Felix
- Trading Halt
- Memphasys announces successful $800,000 Capital Raising
- Memphasys Secures TGA Approval for Felix System
- Appendix 4D - Half-year Financial Report - 31 December 2025
Follow Memphasys into a list and get an email when it puts out news.
Follow Memphasys